Clinical Trial Update: Prevalence of Alpha-1 Antitrypsin Dysfunction in Pulmonary Emphysema [NA]

View source ↗

Summary

A completed clinical trial from Hospices Civils de Lyon evaluating the prevalence of Alpha-1 Antitrypsin deficiency in patients with pulmonary emphysema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency
• Pulmonary Emphysema

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Pulmonary Emphysema | NA | Status: COMPLETED